Zymeworks Inc.
NASDAQ:ZYME · NASDAQ Global Select
-$0.38 today
Vol 0.69M · Avg 0.71M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+85.57%
Period High
$28.56
Period Low
$12.02
Latest
$23.14
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.34B
Trevi Therapeutics, Inc.
NASDAQ:TRVI
$2.40B
Pharvaris N.V.
NASDAQ:PHVS
$2.29B
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$1.91B
Immunome, Inc.
NASDAQ:IMNM
$1.73B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.71B
Ardelyx, Inc.
NASDAQ:ARDX
$1.43B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.39B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.16B
Upstream Bio, Inc.
NASDAQ:UPB
$339.31M
What is the latest ZYME filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does ZYME have?
Intrinsic Alpha currently shows 20 recent filings for ZYME.
Explore More
Continue the stock analysis
Jump to another research area for this company.